David M Griffith1, Matthew E Vale2, Christine Campbell3, Steff Lewis3, Timothy S Walsh2. 1. Department of Anaesthesia, Critical Care and Pain Medicine, Edinburgh Medical School, University of Edinburgh, UK. Electronic address: david.m.griffith@ed.ac.uk. 2. Department of Anaesthesia, Critical Care and Pain Medicine, Edinburgh Medical School, University of Edinburgh, UK. 3. Centre for Population Health Sciences, Edinburgh Medical School, University of Edinburgh, UK.
Abstract
PURPOSE: Physical weakness is common after critical illness; however, it is not clear how best to treat it. Inflammation characterizes critical illness, is associated with loss of muscle mass during critical illness, and potentially modifies post-intensive care unit (ICU) recovery. We sought to identify published reports on the prevalence of systemic inflammation after critical illness and its association with physical recovery. METHODS: This is a systematic review of the literature from MEDLINE, EMBASE, CINAHL, CPCI-SSH, and CPCI-S from January 1982 to December 2011. RESULTS: From 7433 references, 207 full-text articles were reviewed, 57 were eligible, and 22 were included. Inflammation was present in most patients at ICU discharge according to C-reactive protein concentration (range, 70%-100%), procalcitonin (range, 89%-100%), tumor necrosis factor α (100%), and systemic inflammatory response syndrome criteria (range, 92%-95%). Fewer patients had elevated myeloperoxidase concentrations (range, 0%-56%). At hospital discharge, 9 (90%) of 10 chronic obstructive pulmonary disease patients had elevated C-reactive protein. No studies tested the association between inflammation and physical recovery. CONCLUSIONS: Inflammation is present in most patients at ICU discharge, but little is known or has been investigated about persistent inflammation after this time point. No studies have explored the relationship between persistent inflammation and physical recovery. Further research is proposed.
PURPOSE: Physical weakness is common after critical illness; however, it is not clear how best to treat it. Inflammation characterizes critical illness, is associated with loss of muscle mass during critical illness, and potentially modifies post-intensive care unit (ICU) recovery. We sought to identify published reports on the prevalence of systemic inflammation after critical illness and its association with physical recovery. METHODS: This is a systematic review of the literature from MEDLINE, EMBASE, CINAHL, CPCI-SSH, and CPCI-S from January 1982 to December 2011. RESULTS: From 7433 references, 207 full-text articles were reviewed, 57 were eligible, and 22 were included. Inflammation was present in most patients at ICU discharge according to C-reactive protein concentration (range, 70%-100%), procalcitonin (range, 89%-100%), tumor necrosis factor α (100%), and systemic inflammatory response syndrome criteria (range, 92%-95%). Fewer patients had elevated myeloperoxidase concentrations (range, 0%-56%). At hospital discharge, 9 (90%) of 10 chronic obstructive pulmonary disease patients had elevated C-reactive protein. No studies tested the association between inflammation and physical recovery. CONCLUSIONS: Inflammation is present in most patients at ICU discharge, but little is known or has been investigated about persistent inflammation after this time point. No studies have explored the relationship between persistent inflammation and physical recovery. Further research is proposed.
Authors: Mark Luedde; Fabian Benz; Jennifer Niedeggen; Mihael Vucur; Hans-Joerg Hippe; Martina E Spehlmann; Florian Schueller; Sven Loosen; Norbert Frey; Christian Trautwein; Alexander Koch; Tom Luedde; Frank Tacke; Christoph Roderburg Journal: Dis Markers Date: 2016-10-27 Impact factor: 3.434
Authors: Raúl Juárez-Vela; Eva María Andrés-Esteban; Vicente Gea-Caballero; Juan Luis Sánchez-González; Pilar Marcos-Neira; Ainhoa Serrano-Lázaro; Gabriel Tirado-Anglés; Juan Carlos Ruiz-Rodríguez; Ángela Durante; Iván Santolalla-Arnedo; José Antonio García-Erce; Manuel Quintana-Díaz Journal: J Clin Med Date: 2022-02-16 Impact factor: 4.241
Authors: Matthew A Warner; Andrew C Hanson; Ryan D Frank; Phillip J Schulte; Ronald S Go; Curtis B Storlie; Daryl J Kor Journal: JAMA Netw Open Date: 2020-09-01